1. IMPACT OF MAJOR GENOMIC ALTERATIONS ON OUTCOME OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RECEIVING VENETOCLAX PLUS RITUXIMAB IN THE PHASE 3 MURANO STUDY. (12th June 2019) Authors: Wu, J.; Bolen, C.; Seymour, J.F.; Hillmen, P.; Eichhorst, B.; Eldering, E.; Kipps, T.J.; Langerak, A.W.; Mellink, C.; van der Kevie‐Kersemaekers, A.F.; Owen, C.; Chyla, B.; Punnoose, E.A.; Wang, J.; Boyer, M.; Humphrey, K.; Jiang, Y.; Kater, A.P. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 106 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT: RESULTS FROM THE HOVON‐109 STUDY. (12th June 2019) Authors: van der Straten, L.; Hosnijeh, F.; van der Straten, L.; Kater, A.P.; van Oers, M.H.; Posthuma, W.F.; Chamuleau, M.E.; Nijland, M.; Hoogendoorn, M.; De Croon, F.; Wittebol, S.; Kerst, J.; Marijt, E.W.; Raymakers, R.A.; Koene, H.R.; Dobber, J.A.; Tonino, S.H.; Kersting, S.S.; Langerak, A.W.; Levin, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SURVIVAL CONTINUES TO INCREASE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A POPULATION‐BASED ANALYSIS AMONG 20, 324 PATIENTS DIAGNOSED IN THE NETHERLANDS BETWEEN 1989 AND 2015. (12th June 2019) Authors: van der Straten, L.; Levin, M.; Visser, O.; Posthuma, E.F.; Doorduijn, J.K.; Kater, A.P.; Dinmohamed, A.G. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗